AMSBIO Expands US Operations

News Apr 23, 2014

AMSBIO has announced the opening of a new North American headquarters with executive management facilities in Cambridge, MA for its US subsidiary - AMSBIO LLC.

Commenting on this strategic move, Alex Sim (President, AMSBIO) said “The US is the single largest market for our stem cell and regenerative medicine, glycobiology enzymes / substrates and tissue derived products. Drawing upon our in-depth expertise in extracellular matrices we are able to also provide elegant solutions for studying cell motility, migration, invasion and proliferation”.

He added “Our North American customer base has been growing strongly over recent years. From the new East Coast facility we will provide local informed service and support as well as next day delivery of a comprehensive range of enabling technology products to help improve the productivity of our US customers”.

LifeArc Becomes Technology Transfer Partner to London School of Hygiene & Tropical Medicine

News

LifeArc, the medical research charity, has partnered with London School of Hygiene & Tropical Medicine to provide a range of services in technology transfers.

Human Pluripotent Stem Cells Successfully 3D Printed

News

A breakthrough in the 3D-printing of human pluripotent stem cells means scientists are one step closer to being able to 3D print human organs and tissues for transplantation therapy.

Large-Scale Production of Living Brain Cells Enables Entirely New Research

News

After performing a biopsy on the patient, the skin cells are transformed into brain cells that effectively imitate the disease and the age of the patient.